These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18180157)

  • 21. Synthesis and structure guided evaluation of estrogen agonist and antagonist activities of some new tetrazolyl indole derivatives.
    Singh US; Shankar R; Yadav GP; Kharkwal G; Dwivedi A; Keshri G; Singh MM; Moulik PR; Hajela K
    Eur J Med Chem; 2008 Oct; 43(10):2149-58. PubMed ID: 18155810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and SAR studies of indole-based MK2 inhibitors.
    Xiong Z; Gao DA; Cogan DA; Goldberg DR; Hao MH; Moss N; Pack E; Pargellis C; Skow D; Trieselmann T; Werneburg B; White A
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1994-9. PubMed ID: 18291646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Directed evolution of PDZ variants to generate high-affinity detection reagents.
    Ferrer M; Maiolo J; Kratz P; Jackowski JL; Murphy DJ; Delagrave S; Inglese J
    Protein Eng Des Sel; 2005 Apr; 18(4):165-73. PubMed ID: 15820976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural insights into neutrophilic migration revealed by the crystal structure of the chemokine receptor CXCR2 in complex with the first PDZ domain of NHERF1.
    Lu G; Wu Y; Jiang Y; Wang S; Hou Y; Guan X; Brunzelle J; Sirinupong N; Sheng S; Li C; Yang Z
    PLoS One; 2013; 8(10):e76219. PubMed ID: 24098448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway.
    Zheng F; Jewell H; Fitzpatrick J; Zhang J; Mierke DF; Grigoryan G
    J Mol Biol; 2015 Jan; 427(2):491-510. PubMed ID: 25451599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockout mouse models for intestinal electrolyte transporters and regulatory PDZ adaptors: new insights into cystic fibrosis, secretory diarrhoea and fructose-induced hypertension.
    Seidler U; Singh A; Chen M; Cinar A; Bachmann O; Zheng W; Wang J; Yeruva S; Riederer B
    Exp Physiol; 2009 Feb; 94(2):175-9. PubMed ID: 18931049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anthranilic acid based CCK1 antagonists: the 2-indole moiety may represent a "needle" according to the recent homonymous concept.
    Varnavas A; Lassiani L; Valenta V; Berti F; Tontini A; Mennuni L; Makovec F
    Eur J Med Chem; 2004 Jan; 39(1):85-97. PubMed ID: 14987837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors.
    Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Hsu TA; Yueh A; Chao YS; Chern JH
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4134-8. PubMed ID: 19539472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Creating conformational entropy by increasing interdomain mobility in ligand binding regulation: a revisit to N-terminal tandem PDZ domains of PSD-95.
    Wang W; Weng J; Zhang X; Liu M; Zhang M
    J Am Chem Soc; 2009 Jan; 131(2):787-96. PubMed ID: 19072119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer based design, synthesis and biological evaluation of novel indole derivatives as HCV NS3-4A serine protease inhibitors.
    Ismail NS; El Dine RS; Hattori M; Takahashi K; Ihara M
    Bioorg Med Chem; 2008 Sep; 16(17):7877-87. PubMed ID: 18752958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent developments in de novo design and scaffold hopping.
    Mauser H; Guba W
    Curr Opin Drug Discov Devel; 2008 May; 11(3):365-74. PubMed ID: 18428090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitors.
    Schirok H; Kast R; Figueroa-Pérez S; Bennabi S; Gnoth MJ; Feurer A; Heckroth H; Thutewohl M; Paulsen H; Knorr A; Hütter J; Lobell M; Münter K; Geiss V; Ehmke H; Lang D; Radtke M; Mittendorf J; Stasch JP
    ChemMedChem; 2008 Dec; 3(12):1893-904. PubMed ID: 18973168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
    Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA
    Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
    Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
    Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.
    Bell MG; Gernert DL; Grese TA; Belvo MD; Borromeo PS; Kelley SA; Kennedy JH; Kolis SP; Lander PA; Richey R; Sharp VS; Stephenson GA; Williams JD; Yu H; Zimmerman KM; Steinberg MI; Jadhav PK
    J Med Chem; 2007 Dec; 50(26):6443-5. PubMed ID: 18038968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rational design of novel, potent small molecule pan-selectin antagonists.
    Kranich R; Busemann AS; Bock D; Schroeter-Maas S; Beyer D; Heinemann B; Meyer M; Schierhorn K; Zahlten R; Wolff G; Aydt EM
    J Med Chem; 2007 Mar; 50(6):1101-15. PubMed ID: 17302397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol modulates cell signaling and protein networking by specifically interacting with PDZ domain-containing scaffold proteins.
    Sheng R; Chen Y; Yung Gee H; Stec E; Melowic HR; Blatner NR; Tun MP; Kim Y; Källberg M; Fujiwara TK; Hye Hong J; Pyo Kim K; Lu H; Kusumi A; Goo Lee M; Cho W
    Nat Commun; 2012; 3():1249. PubMed ID: 23212378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and melatoninergic activity of new azido- and isothiocyanato-substituted indoles.
    Tsotinis A; Afroudakis PA; Davidson K; Prashar A; Sugden D
    J Med Chem; 2007 Dec; 50(25):6436-40. PubMed ID: 17988084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.